At Axela, we create tools and content to simplify multiplex biomarker detection for translational research and diagnostic testing. Our systems are built upon advanced flow-through technologies that enable rapid, real time multiplex immunoassays as well as high performance nucleic acid and protein microarray analysis. We provide easy to use, automated platforms with the flexibility of generating custom assays that can accelerate the transition of biomarker discoveries from the research laboratory to the clinic. These platforms are especially designed for partners focused on developing near patient tests in the areas of oncology, immunology, or for specialty applications such as traumatic brain injury.